Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CandyButcher 

Merck & Co. Inc. diskutieren

Merck & Co. Inc.

WKN: A0YD8Q / Symbol: MRK / Name: Merck & Co / Aktie / Pharmazeutika / Large Cap /

103,80 €
-0,76 %

Einschätzung Buy
Rendite (%) 20,14 %
Kursziel 110,77
Veränderung
Endet am 12.02.26

Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $122.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 51,09 %
Kursziel 101,20
Veränderung
Endet am 17.04.26

Merck & Co., Inc. (NYSE: MRK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $115.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 19,17 %
Kursziel 108,59
Veränderung
Endet am 24.11.26

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $125.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 19,45 %
Kursziel 103,37
Veränderung
Endet am 02.12.26

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $92.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 22,12 %
Kursziel 102,22
Veränderung
Endet am 15.12.26

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Bank of America Corporation from $105.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 21,55 %
Kursziel 110,75
Veränderung
Endet am 18.12.26

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $130.00 price target on the stock, up previously from $82.00.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 11,49 %
Kursziel 111,10
Veränderung
Endet am 07.01.27

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at UBS Group AG from $105.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,80 %
Kursziel 114,17
Veränderung
Endet am 04.02.27

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Wells Fargo & Company from $125.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,19 %
Kursziel 118,75
Veränderung
Endet am 06.02.27

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Guggenheim from $122.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Merck & Co., Inc. (NYSE:MRK) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,76 %
Kursziel 126,38
Veränderung
Endet am 13.02.27

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $150.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 119,08
Veränderung
Endet am 20.02.27

Merck & Co., Inc. (NYSE:MRK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $140.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,52 %
Kursziel 120,47
Veränderung
Endet am 25.02.27

Merck & Co., Inc. (MRK) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat